ASTERDM vs LOTUSEYE: Stock Comparison

Aster DM Healthcare Limited vs Lotus Eye Hospital and Institute Limited

Live data: 6 August 2026, 4:08 PM IST • Source: NSE and company filings

Aster DM Healthcare Limited is the larger company by market capitalisation. Aster DM Healthcare Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Lotus Eye Hospital and Institute Limited shows lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Aster DM Healthcare Limited and Lotus Eye Hospital and Institute Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ASTERDM is more favourable on 9 of 13 scored metrics and LOTUSEYE on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ASTERDM is the larger company
₹73,443 Cr vs ₹246 Cr
P/E Ratio
ASTERDM has a lower P/E
113.48x vs 2,925x
P/B Ratio
LOTUSEYE has a lower P/B
4.05x vs 9.62x
EPS
ASTERDM has higher earnings per share
₹7.51 vs ₹0.04
Dividend Yield
ASTERDM has a higher dividend yield
0.48% vs 0%
EPS Growth (TTM YoY)
ASTERDM has faster EPS growth
71.5% vs 0%
Qtr Profit Growth
ASTERDM has stronger quarterly profit growth
42% vs -224%
ROE
ASTERDM has a higher ROE
10.7% vs 0.13%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricASTERDMLOTUSEYE
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricASTERDMLOTUSEYE
Live Price₹844.45₹117.24
Day Change0.28%-0.5%
Volume24.39 L2,460
52-Week High₹856.75₹147
52-Week Low₹519.1₹70.84
Distance from 52W High-1.44%-20.24%

Valuation

MetricASTERDMLOTUSEYE
Market Cap₹73,443 Cr₹246 Cr
P/E Ratio113.48x2,925x
P/B Ratio9.62x4.05x
EPS₹7.51₹0.04
Book Value₹88.8₹28.23
Dividend Yield0.48%0%

Growth

MetricASTERDMLOTUSEYE
Revenue Growth (TTM YoY)18.2%18.2%
EPS Growth (TTM YoY)71.5%0%
Qtr Sales Growth18.2%18.2%
Qtr Profit Growth42%-224%

Profitability & Leverage

MetricASTERDMLOTUSEYE
ROE10.7%0.13%
ROCE11.4%1.16%
Net Margin6.45%0.15%
Operating Margin18.6%6.29%
Debt to Equity0.49x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricASTERDMLOTUSEYE
Promoter Holding40.39%37.39%
FII Holding10.53% 6.65 pp0%
DII Holding27.65% 0.08 pp0.02%
Public Holding21.42% 6.8 pp59.85% 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Aster DM Healthcare Limited and Lotus Eye Hospital and Institute Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.